nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlordiazepoxide—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.03	0.0644	CbGeAlD
Chlordiazepoxide—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0274	0.0588	CbGeAlD
Chlordiazepoxide—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0265	0.0568	CbGeAlD
Chlordiazepoxide—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.0243	0.906	CrCbGaD
Chlordiazepoxide—GABRB2—brainstem—amyotrophic lateral sclerosis	0.0172	0.0369	CbGeAlD
Chlordiazepoxide—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0157	0.0337	CbGeAlD
Chlordiazepoxide—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0152	0.0326	CbGeAlD
Chlordiazepoxide—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.012	0.0257	CbGeAlD
Chlordiazepoxide—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.012	0.0257	CbGeAlD
Chlordiazepoxide—GABRA5—nervous system—amyotrophic lateral sclerosis	0.0119	0.0255	CbGeAlD
Chlordiazepoxide—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0116	0.0249	CbGeAlD
Chlordiazepoxide—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.0114	0.0245	CbGeAlD
Chlordiazepoxide—GABRA3—nervous system—amyotrophic lateral sclerosis	0.011	0.0237	CbGeAlD
Chlordiazepoxide—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.0107	0.0229	CbGeAlD
Chlordiazepoxide—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.0107	0.0229	CbGeAlD
Chlordiazepoxide—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.0106	0.0228	CbGeAlD
Chlordiazepoxide—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.0106	0.0227	CbGeAlD
Chlordiazepoxide—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00993	0.0196	CbGpPWpGaD
Chlordiazepoxide—GABRA5—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00965	0.019	CbGpPWpGaD
Chlordiazepoxide—GABRA3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00948	0.0187	CbGpPWpGaD
Chlordiazepoxide—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00943	0.0203	CbGeAlD
Chlordiazepoxide—GABRA2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00931	0.0184	CbGpPWpGaD
Chlordiazepoxide—GABRB3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00925	0.0182	CbGpPWpGaD
Chlordiazepoxide—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.0092	0.0198	CbGeAlD
Chlordiazepoxide—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00909	0.0179	CbGpPWpGaD
Chlordiazepoxide—GABRA5—brain—amyotrophic lateral sclerosis	0.00907	0.0195	CbGeAlD
Chlordiazepoxide—GABRB2—nervous system—amyotrophic lateral sclerosis	0.009	0.0193	CbGeAlD
Chlordiazepoxide—GABRG2—nervous system—amyotrophic lateral sclerosis	0.009	0.0193	CbGeAlD
Chlordiazepoxide—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00867	0.0186	CbGeAlD
Chlordiazepoxide—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00867	0.0186	CbGeAlD
Chlordiazepoxide—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00847	0.0182	CbGeAlD
Chlordiazepoxide—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00847	0.0182	CbGeAlD
Chlordiazepoxide—GABRA3—brain—amyotrophic lateral sclerosis	0.00844	0.0181	CbGeAlD
Chlordiazepoxide—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00823	0.0177	CbGeAlD
Chlordiazepoxide—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.0082	0.0176	CbGeAlD
Chlordiazepoxide—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00795	0.0171	CbGeAlD
Chlordiazepoxide—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.00794	0.0157	CbGpPWpGaD
Chlordiazepoxide—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00792	0.017	CbGeAlD
Chlordiazepoxide—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00774	0.0166	CbGeAlD
Chlordiazepoxide—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00765	0.0164	CbGeAlD
Chlordiazepoxide—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00748	0.0161	CbGeAlD
Chlordiazepoxide—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00715	0.0141	CbGpPWpGaD
Chlordiazepoxide—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00691	0.0148	CbGeAlD
Chlordiazepoxide—GABRB2—brain—amyotrophic lateral sclerosis	0.00688	0.0148	CbGeAlD
Chlordiazepoxide—GABRG2—brain—amyotrophic lateral sclerosis	0.00688	0.0148	CbGeAlD
Chlordiazepoxide—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00666	0.0143	CbGeAlD
Chlordiazepoxide—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00665	0.0143	CbGeAlD
Chlordiazepoxide—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00651	0.014	CbGeAlD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.00645	0.0127	CbGpPWpGaD
Chlordiazepoxide—GABRA2—brain—amyotrophic lateral sclerosis	0.00629	0.0135	CbGeAlD
Chlordiazepoxide—GABRA1—brain—amyotrophic lateral sclerosis	0.00608	0.013	CbGeAlD
Chlordiazepoxide—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00562	0.0111	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00546	0.0108	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00536	0.0106	CbGpPWpGaD
Chlordiazepoxide—GABRB3—brain—amyotrophic lateral sclerosis	0.00528	0.0113	CbGeAlD
Chlordiazepoxide—GABRA2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00527	0.0104	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00524	0.0103	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00514	0.0101	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00457	0.009	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00449	0.00886	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00444	0.00875	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00436	0.00859	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00428	0.00844	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00425	0.00838	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00422	0.00831	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00418	0.00823	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00409	0.00807	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00402	0.00793	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00395	0.00779	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00394	0.00776	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00393	0.00774	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00386	0.0076	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00384	0.00757	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00372	0.00734	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00365	0.0072	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00362	0.00713	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00355	0.007	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00354	0.0076	CbGeAlD
Chlordiazepoxide—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00349	0.00688	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00348	0.00748	CbGeAlD
Chlordiazepoxide—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00347	0.00683	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00343	0.00677	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00341	0.00732	CbGeAlD
Chlordiazepoxide—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00341	0.00671	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00337	0.00664	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00336	0.00662	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00335	0.0072	CbGeAlD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00334	0.00657	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00328	0.00704	CbGeAlD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00328	0.00646	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00322	0.00634	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0032	0.0063	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00317	0.00625	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00314	0.00619	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00308	0.00607	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00306	0.00603	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00302	0.00596	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00298	0.00587	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00297	0.00586	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00297	0.00586	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00295	0.00582	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00292	0.00575	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0029	0.00571	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00287	0.00565	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00285	0.00562	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0028	0.00552	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0028	0.00552	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00274	0.00541	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00274	0.0054	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00272	0.00536	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00267	0.00526	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—brain—amyotrophic lateral sclerosis	0.00266	0.00572	CbGeAlD
Chlordiazepoxide—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00263	0.00519	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00262	0.00517	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00261	0.00514	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0026	0.00513	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0026	0.00513	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00256	0.00505	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00256	0.00504	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00254	0.005	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00254	0.005	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00254	0.005	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00253	0.00499	CbGpPWpGaD
Chlordiazepoxide—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.00253	0.0942	CrCbGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00253	0.00498	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00253	0.00498	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00251	0.00495	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00248	0.00489	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00248	0.00489	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00247	0.00486	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00245	0.00483	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00245	0.00482	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00244	0.00481	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00244	0.00481	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00243	0.00479	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00242	0.00478	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00242	0.00478	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00241	0.00474	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00238	0.00469	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00238	0.00469	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00236	0.00465	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00234	0.00462	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00232	0.00457	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00232	0.00457	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00228	0.00449	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00228	0.00449	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00226	0.00446	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00225	0.00444	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00224	0.00441	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00224	0.00441	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00222	0.00438	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00221	0.00436	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0022	0.00433	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00218	0.0043	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00217	0.00429	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00217	0.00427	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00216	0.00426	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00214	0.00423	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00214	0.00423	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00212	0.00418	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0021	0.00415	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00208	0.00411	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00208	0.0041	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00208	0.0041	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00205	0.00403	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00201	0.00396	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.002	0.00394	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00199	0.00393	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00199	0.00393	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00196	0.00387	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00196	0.00386	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00194	0.00383	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00194	0.00382	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00194	0.00382	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0019	0.00375	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0019	0.00375	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0019	0.00375	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00187	0.00369	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00187	0.00369	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00187	0.00368	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00187	0.00368	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00187	0.00368	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00186	0.00366	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00186	0.00366	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00185	0.00365	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00183	0.00362	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00182	0.00359	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00182	0.00359	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00182	0.00359	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00179	0.00353	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00178	0.0035	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00173	0.0034	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00171	0.00338	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0017	0.00334	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00167	0.00328	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00166	0.00326	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00163	0.00321	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00163	0.0032	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00159	0.00314	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00159	0.00314	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00156	0.00308	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00142	0.0028	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00133	0.00263	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00131	0.00259	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00126	0.00248	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00122	0.00241	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.0012	0.00237	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00118	0.00233	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00231	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00115	0.00227	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00107	0.00211	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00107	0.00211	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00104	0.00205	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00104	0.00205	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00102	0.00202	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00102	0.00202	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00101	0.00199	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00101	0.00198	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00101	0.00198	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000998	0.00197	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000998	0.00197	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00098	0.00193	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00098	0.00193	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000955	0.00188	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000928	0.00183	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000911	0.0018	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000896	0.00177	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00089	0.00175	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000874	0.00172	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000871	0.00172	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000857	0.00169	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000857	0.00169	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000815	0.00161	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000764	0.00151	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000656	0.00129	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000596	0.00118	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000588	0.00116	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000557	0.0011	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000457	0.0009	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000457	0.0009	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000418	0.000824	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00039	0.000768	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000388	0.000766	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000384	0.000758	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000365	0.00072	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.00033	0.000651	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000299	0.000589	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000299	0.000589	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000273	0.000538	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000254	0.000501	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00025	0.000493	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000239	0.000471	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000231	0.000455	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000216	0.000426	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00019	0.000374	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000164	0.000323	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000151	0.000298	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000124	0.000244	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000102	0.000201	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.37e-05	0.000185	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	7.71e-05	0.000152	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.67e-05	0.000131	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.13e-05	0.000121	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.28e-05	0.000104	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.04e-05	9.93e-05	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.45e-05	6.81e-05	CbGpPWpGaD
